Monitor for actual sale execution via future Form 4 filings; given the small size (<0.1% of $1.1B market cap) and routine nature of post-vesting sales, significant market impact is unlikely unless part of a broader insider selling pattern.
Price Chart
Executive Summary
Lillie James Woodruff, an officer of MapLight Therapeutics (MPLT), filed a Form 144 notifying intent to sell up to 4,896 shares of common stock, representing a portion of previously granted restricted stock units. The sale is proposed to occur on or after April 15, 2026, through Jefferies LLC on Nasdaq.
Key Facts
- Reporting person: Lillie James Woodruff, officer of MapLight Therapeutics
- Number of shares proposed for sale: 4,896
- Approximate dollar value: $132,290 (based on $27/share market price)
- Shares sourced from RSU grants dated July 30, 2023 (3,200 shares), November 9, 2023 (1,434 shares), and May 2, 2024 (6,147 shares)
- Form 144 filed on April 15, 2026, with proposed sale date effective the same day
- Broker: Jefferies LLC; Trading venue: Nasdaq
Financial Impact
Minimal dilution or cash flow impact; potential minor downward pressure if shares are sold near market price of $27/share
Risk Factors
- Perception of lack of confidence if this sale is part of a larger insider divestment trend
- Potential short-term sentiment pressure if sale is executed rapidly
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001974158-26-000047 |
| Document: 0001974158-26-000047-index.html | 0001974158-26-000047 |
| Document: 0001974158-26-000047.txt | 0001974158-26-000047 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | Insider Cluster | $8.00 | awaiting T+20 | — | $7.66 (+4.25%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.66 (−0.52%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.66 (−0.52%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.66 (−0.52%) |
Sep 24, 2026 4w ago | EFFECT | $10.76 $8.25 | ▼ −23.33% | ▼ −22.91% | $7.66 (−28.81%) |
Sep 18, 2026 5w ago | S-1/A | $10.90 $8.00 | ▼ −26.61% | ▼ −25.70% | $7.66 (−29.72%) |
Aug 4, 2026 11w ago | Insider Cluster | $12.92 $13.06 | ▲ +1.08% | ▲ +1.69% | $7.66 (−40.71%) |
Aug 3, 2026 12w ago | 144 | $12.94 $13.31 | ▲ +2.86% | ▲ +4.10% | $7.66 (−40.80%) |
Jul 30, 2026 12w ago | 144 | $13.02 $12.60 | ▲ +3.23% | ▲ +6.21% | $7.66 (+41.17%) |
Jul 28, 2026 12w ago | Insider Buy | $15.02 $12.86 | ▼ −14.38% | ▼ −19.40% | $7.66 (−49.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers